PERCEPTIVE ADVISORS LLC 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Sale |
2024-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 24,245,952 8.100% |
-3,811,504 (-13.58%) |
Filing |
| 2024-02-14 4:38 pm Purchase |
2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 28,057,456 9.600% |
414,539 (+1.50%) |
Filing |
| 2023-02-14 2:31 pm Purchase |
2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 27,642,917 9.800% |
286,874 (+1.05%) |
Filing |
| 2022-03-02 4:16 pm Sale |
2022-02-23 | 13G | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 27,356,043 9.700% |
-400 (-0.00%) |
Filing |
| 2022-03-02 3:38 pm Purchase |
2022-02-23 | 13D | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 27,356,443 9.700% |
797,000 (+3.00%) |
Filing |
| 2022-02-22 5:19 pm Unchanged |
2021-07-02 | 13D | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 26,559,443 9.500% |
0 (Unchanged) |
Filing |
| 2022-02-14 3:45 pm Purchase |
2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 26,559,443 9.500% |
1,447,395 (+5.76%) |
Filing |
| 2021-02-16 3:33 pm Sale |
2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 25,112,048 9.700% |
-20,316 (-0.08%) |
Filing |